The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $53.97

Today's change-0.42 -0.77%
Updated May 26 4:02 PM EDT. Delayed by at least 15 minutes.
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $53.97

Today's change-0.42 -0.77%
Updated May 26 4:02 PM EDT. Delayed by at least 15 minutes.

Bristol-Myers Squibb Co down (U.S.)$0.42

Bristol-Myers Squibb Co closed lower Friday, dropping (U.S.)$0.42 or 0.77% to (U.S.)$53.97. Although unchanged over the last five days, shares are down 7.65% for the last year to date. This security has underperformed the S&P 500 by 39.28% during the last year.

Key company metrics

  • Open(U.S.) $54.37
  • Previous close(U.S.) $54.39
  • High(U.S.) $54.82
  • Low(U.S.) $53.90
  • Bid / Ask-- / --
  • YTD % change-7.65%
  • Volume4,968,194
  • Average volume (10-day)7,248,105
  • Average volume (1-month)7,919,942
  • Average volume (3-month)11,506,989
  • 52-week range(U.S.) $46.01 to (U.S.) $77.12
  • Beta1.19
  • Trailing P/E18.72×
  • P/E 1 year forward18.33×
  • Forward PEG1.99×
  • Indicated annual dividend(U.S.) $1.56
  • Dividend yield2.89%
  • Trailing EPS(U.S.) $2.88
Updated May 26 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.03%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue4,9295,2434,9224,871
Total other revenue--------
Total revenue4,9295,2434,9224,871
Gross profit3,6703,8663,6243,669
Total cost of revenue1,2591,3771,2981,202
Total operating expense2,9684,1153,3693,210
Selling / general / administrative1,0741,4611,1441,238
Research & development1,2881,4001,1381,266
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-45417-53-329
Other operating expenses, total-199-140-158-167
Operating income1,9611,1281,5531,661
Interest income (expense), net non-operating-45-40-42-42
Gain (loss) on sale of assets--------
Other--------
Income before tax1,9551,0861,5591,615
Income after tax1,5268981,2151,188
Income tax, total429188344427
Net income1,5748941,2021,166
Total adjustments to net income--------
Net income before extra. items1,5748941,2021,166
Minority interest48-4-13-22
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,5748941,2021,166
Inc. avail. to common incl. extra. items1,5748941,2021,166
Diluted net income1,5748941,2021,166
Dilution adjustment--------
Diluted weighted average shares1,6711,6831,6791,679
Diluted EPS excluding extraordinary itemsvalue per share0.940.530.720.69
Dividends per sharevalue per share0.390.380.380.38
Diluted normalized EPSvalue per share0.730.540.690.55